Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Liposomal vaccine delivery systems.
Henriksen-Lacey M, Korsholm KS, Andersen P, Perrie Y, Christensen D. Henriksen-Lacey M, et al. Among authors: korsholm ks. Expert Opin Drug Deliv. 2011 Apr;8(4):505-19. doi: 10.1517/17425247.2011.558081. Epub 2011 Mar 18. Expert Opin Drug Deliv. 2011. PMID: 21413904 Review.
Cationic liposomes as vaccine adjuvants.
Christensen D, Korsholm KS, Andersen P, Agger EM. Christensen D, et al. Among authors: korsholm ks. Expert Rev Vaccines. 2011 Apr;10(4):513-21. doi: 10.1586/erv.11.17. Expert Rev Vaccines. 2011. PMID: 21506648 Review.
The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile.
Schmidt ST, Khadke S, Korsholm KS, Perrie Y, Rades T, Andersen P, Foged C, Christensen D. Schmidt ST, et al. Among authors: korsholm ks. J Control Release. 2016 Oct 10;239:107-17. doi: 10.1016/j.jconrel.2016.08.034. Epub 2016 Aug 26. J Control Release. 2016. PMID: 27574990 Free PMC article.
Comparison of two different PEGylation strategies for the liposomal adjuvant CAF09: Towards induction of CTL responses upon subcutaneous vaccine administration.
Schmidt ST, Olsen CL, Franzyk H, Wørzner K, Korsholm KS, Rades T, Andersen P, Foged C, Christensen D. Schmidt ST, et al. Among authors: korsholm ks. Eur J Pharm Biopharm. 2019 Jul;140:29-39. doi: 10.1016/j.ejpb.2019.04.020. Epub 2019 May 2. Eur J Pharm Biopharm. 2019. PMID: 31055066 Free article.
Cationic liposomes as vaccine adjuvants.
Christensen D, Korsholm KS, Rosenkrands I, Lindenstrøm T, Andersen P, Agger EM. Christensen D, et al. Among authors: korsholm ks. Expert Rev Vaccines. 2007 Oct;6(5):785-96. doi: 10.1586/14760584.6.5.785. Expert Rev Vaccines. 2007. PMID: 17931158 Review.
A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog.
Christensen D, Henriksen-Lacey M, Kamath AT, Lindenstrøm T, Korsholm KS, Christensen JP, Rochat AF, Lambert PH, Andersen P, Siegrist CA, Perrie Y, Agger EM. Christensen D, et al. Among authors: korsholm ks. J Control Release. 2012 Jun 28;160(3):468-76. doi: 10.1016/j.jconrel.2012.03.016. Epub 2012 Mar 27. J Control Release. 2012. PMID: 22709414
Induction of Cytotoxic T-Lymphocyte Responses Upon Subcutaneous Administration of a Subunit Vaccine Adjuvanted With an Emulsion Containing the Toll-Like Receptor 3 Ligand Poly(I:C).
Schmidt ST, Pedersen GK, Neustrup MA, Korsholm KS, Rades T, Andersen P, Foged C, Christensen D. Schmidt ST, et al. Among authors: korsholm ks. Front Immunol. 2018 Apr 30;9:898. doi: 10.3389/fimmu.2018.00898. eCollection 2018. Front Immunol. 2018. PMID: 29760705 Free PMC article.
32 results